Insider Selling: Atlassian (NASDAQ:TEAM) Director Sells $1,188,688.20 in Stock

Atlassian Corporation PLC (NASDAQ:TEAMGet Free Report) Director Scott Farquhar sold 7,665 shares of the stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $155.08, for a total transaction of $1,188,688.20. Following the completion of the sale, the director directly owned 145,635 shares of the company’s stock, valued at $22,585,075.80. This trade represents a 5.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Scott Farquhar also recently made the following trade(s):

  • On Friday, November 28th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $150.12, for a total value of $1,150,669.80.
  • On Wednesday, November 26th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $148.29, for a total value of $1,136,642.85.
  • On Monday, November 24th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $146.62, for a total transaction of $1,123,842.30.
  • On Friday, November 21st, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $144.02, for a total transaction of $1,103,913.30.
  • On Wednesday, November 19th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.63, for a total value of $1,131,583.95.
  • On Monday, November 17th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $147.41, for a total value of $1,129,897.65.
  • On Thursday, November 13th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $153.77, for a total transaction of $1,178,647.05.
  • On Monday, November 10th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $158.00, for a total transaction of $1,211,070.00.
  • On Friday, November 7th, Scott Farquhar sold 7,665 shares of Atlassian stock. The stock was sold at an average price of $155.58, for a total value of $1,192,520.70.
  • On Wednesday, November 5th, Scott Farquhar sold 7,665 shares of Atlassian stock. The shares were sold at an average price of $162.66, for a total transaction of $1,246,788.90.

Atlassian Stock Performance

Atlassian stock traded down $0.22 during midday trading on Thursday, reaching $156.54. 1,852,889 shares of the stock traded hands, compared to its average volume of 2,503,511. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 0.72. The firm has a fifty day moving average price of $155.46 and a two-hundred day moving average price of $177.95. The firm has a market cap of $41.19 billion, a price-to-earnings ratio of -220.48, a PEG ratio of 29.03 and a beta of 0.89. Atlassian Corporation PLC has a fifty-two week low of $139.70 and a fifty-two week high of $326.00.

Atlassian (NASDAQ:TEAMGet Free Report) last posted its earnings results on Thursday, October 30th. The technology company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.83 by $0.21. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.40 billion. During the same period last year, the firm earned $0.77 EPS. The firm’s revenue was up 20.6% compared to the same quarter last year. On average, equities research analysts forecast that Atlassian Corporation PLC will post -0.34 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. Capco Asset Management LLC acquired a new position in Atlassian during the 2nd quarter valued at $25,000. Physician Wealth Advisors Inc. boosted its holdings in Atlassian by 60.4% during the third quarter. Physician Wealth Advisors Inc. now owns 162 shares of the technology company’s stock valued at $26,000 after purchasing an additional 61 shares in the last quarter. Atlantic Union Bankshares Corp boosted its stake in Atlassian by 19,900.0% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 200 shares of the technology company’s stock valued at $32,000 after buying an additional 199 shares in the last quarter. Geneos Wealth Management Inc. grew its holdings in shares of Atlassian by 447.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after purchasing an additional 161 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd bought a new stake in Atlassian during the third quarter worth about $57,000. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TEAM has been the subject of several recent analyst reports. Truist Financial set a $210.00 price objective on shares of Atlassian in a report on Friday, October 31st. KeyCorp cut their price objective on Atlassian from $250.00 to $210.00 and set an “overweight” rating on the stock in a report on Thursday, October 23rd. TD Cowen reduced their target price on Atlassian from $220.00 to $205.00 and set a “hold” rating for the company in a report on Monday, October 27th. Canaccord Genuity Group reissued a “buy” rating and issued a $230.00 price target on shares of Atlassian in a research report on Wednesday, October 22nd. Finally, Zacks Research raised Atlassian from a “strong sell” rating to a “hold” rating in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $240.00.

Check Out Our Latest Analysis on TEAM

About Atlassian

(Get Free Report)

Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.

Featured Stories

Insider Buying and Selling by Quarter for Atlassian (NASDAQ:TEAM)

Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.